Evidence map›Paper›PMID 29913259›Full record

ArticleJournal of the American Academy of Dermatology2018

Fibroproliferative genes are preferentially expressed in central centrifugal cicatricial alopecia.

Crystal Aguh, Yemisi Dina, C Conover Talbot, Luis Garza

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06946550 narecruitingnot on this mapstarted 2025, after this paper: background citation

1470 nm Non-Ablative Laser for the Treatment of Scarring Alopecia: A Clinical and Mechanistic Study

TypeinterventionalSponsorMontefiore Medical CenterRan2025 to 2027Enrolled5ConditionsScarring AlopeciaArms1470nm non-ablative fractional laser
NCT07734870 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Tirzepatide for Treatment of CCCA

TypeinterventionalSponsorJohns Hopkins UniversityRan2026 to 2028Enrolled20ConditionsCentral Centrifugal Cicatricial Alopecia (CCCA)ArmsTirzepatide
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Crystal AguhDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland. Electronic address: cagi1@jhmi.edu.
Yemisi DinaMeharry Medical College, Nashville, Tennessee.
C Conover TalbotJohns Hopkins Medical Institute Deep Sequencing and Microarray Core, Baltimore, Maryland.
Luis GarzaDepartment of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland.
Johns Hopkins University · USMeharry Medical College · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
NRSA Training CoreTL1TR002244 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Julie A. Bastarache · 2017 to 2026
$4.6M
Mechanism and clinical pilot tst of volar fibroblast to create ectopic volar skinR01AR064297 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI GARZA, LUIS ANDRES · 2013 to 2017
$1.8M
Towards the clinical testing of dsRNA to promote wound induced hair neogenesisR01AR068280 · NIAMS · JOHNS HOPKINS UNIVERSITY · PI GARZA, LUIS ANDRES · 2016 to 2018
$718k
NCATS NIH HHS TL1 TR002244NCRR NIH HHS UL1 RR024975NIAMS NIH HHS R01 AR064297NIAMS NIH HHS R01 AR068280
6 · The paper itself

Abstract

backgroundCentral centrifugal cicatricial alopecia (CCCA) is a primary cicatricial alopecia that most commonly affects women of African descent. Like CCCA, fibroproliferative disorders (FPDs) such as keloids, atherosclerosis, and fibroids are characterized by low-grade inflammation and irritation, resulting in end-stage fibrosis.

objectiveWe sought to determine whether fibroproliferative genes were up-regulated in patients with CCCA.

methodsA total of 5 patients with biopsy-proven CCCA were recruited for this study. Two scalp biopsy specimens were obtained from each patient; 1 from CCCA-affected vertex scalp and 1 from the unaffected occipital scalp. Microarray analysis was performed to determine the differential gene expression patterns.

resultsThere was an upregulation of genes implicated in FPDs in patients with CCCA. Specifically, we noted increased expression of platelet derived growth factor gene (PDGF), collagen I gene (COL I), collagen III gene (COL III), matrix metallopeptidase 1 gene (MMP1), matrix metallopeptidase 2 gene (MMP2), matrix metallopeptidase 7 gene (MMP7), and matrix metallopeptidase 9 gene (MMP9) in affected scalp compared with in unaffected scalp. Significant overlap in the canonic pathways was noted between patients with CCCA and patients with both atherosclerosis and hepatic fibrosis (P < .001). LIMITATIONS: Small sample size and the use of whole skin tissue for analysis.

conclusionWe have identified the upregulation of critical genes implicated in FPDs in the gene expression profile of patients with CCCA. These findings may help identify future therapeutic targets for this otherwise difficult-to-treat condition.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAlopeciaBiopsy, NeedleCicatrixFemaleHumansImmunohistochemistryMaleMiddle AgedPlatelet-Derived Growth FactorPrognosisRisk AssessmentSampling StudiesUp-RegulationPlatelet-Derived Growth Factorplatelet-derived growth factor Aalopeciacentral centrifugal cicatricial alopeciacicatricial alopeciafibroproliferative disordersfibrosistherapy

Identifiers

PMID29913259
PMCPMC6348462
OpenAlexW2808823425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.